Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 28

1.

Targeting the hypoxia-inducible factor (HIF) pathway in cancer.

Poon E, Harris AL, Ashcroft M.

Expert Rev Mol Med. 2009 Aug 27;11:e26. doi: 10.1017/S1462399409001173. Review.

PMID:
19709449
[PubMed - indexed for MEDLINE]
2.

Modulation of adaptive immunity with Toll-like receptors.

Manicassamy S, Pulendran B.

Semin Immunol. 2009 Aug;21(4):185-93. doi: 10.1016/j.smim.2009.05.005. Epub 2009 Jun 6. Review.

PMID:
19502082
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells.

Li Z, Bao S, Wu Q, Wang H, Eyler C, Sathornsumetee S, Shi Q, Cao Y, Lathia J, McLendon RE, Hjelmeland AB, Rich JN.

Cancer Cell. 2009 Jun 2;15(6):501-13. doi: 10.1016/j.ccr.2009.03.018.

PMID:
19477429
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Induction of heat shock proteins 27 and 72 in retinal ganglion cells after acute pressure-induced ischaemia.

Windisch BK, LeVatte TL, Archibald ML, Chauhan BC.

Clin Experiment Ophthalmol. 2009 Apr;37(3):299-307.

PMID:
19472539
[PubMed - indexed for MEDLINE]
5.

Physiologic oxygen concentration enhances the stem-like properties of CD133+ human glioblastoma cells in vitro.

McCord AM, Jamal M, Shankavaram UT, Lang FF, Camphausen K, Tofilon PJ.

Mol Cancer Res. 2009 Apr;7(4):489-97. doi: 10.1158/1541-7786.MCR-08-0360. Erratum in: Mol Cancer Res. 2009 Jun;7(6):987. Shankavarum, Uma T [corrected to Shankavaram, Uma T].

PMID:
19372578
[PubMed - indexed for MEDLINE]
Free Article
6.

T regulatory cells: hypoxia-adenosinergic suppression and re-direction of the immune response.

Sitkovsky MV.

Trends Immunol. 2009 Mar;30(3):102-8. doi: 10.1016/j.it.2008.12.002. Epub 2009 Feb 7.

PMID:
19201652
[PubMed - indexed for MEDLINE]
7.

Cancer vaccines: will we ever learn?

Johnson RS, Walker AI, Ward SJ.

Expert Rev Anticancer Ther. 2009 Jan;9(1):67-74. doi: 10.1586/14737140.9.1.67.

PMID:
19105708
[PubMed - indexed for MEDLINE]
8.

Freeze-and-thaw-disrupted tumour cells impair the responsiveness of DC to TLR stimulation.

Tirapu I, Lewis A, Kreutz M, McLinden H, Diebold SS.

Eur J Immunol. 2008 Oct;38(10):2740-50. doi: 10.1002/eji.200838284.

PMID:
18825742
[PubMed - indexed for MEDLINE]
9.

Effective CpG immunotherapy of breast carcinoma prevents but fails to eradicate established brain metastasis.

Xiong Z, Gharagozlou S, Vengco I, Chen W, Ohlfest JR.

Clin Cancer Res. 2008 Sep 1;14(17):5484-93. doi: 10.1158/1078-0432.CCR-07-4139.

PMID:
18765540
[PubMed - indexed for MEDLINE]
Free Article
10.

Optimization of dendritic cell loading with tumor cell lysates for cancer immunotherapy.

Hatfield P, Merrick AE, West E, O'Donnell D, Selby P, Vile R, Melcher AA.

J Immunother. 2008 Sep;31(7):620-32. doi: 10.1097/CJI.0b013e31818213df.

PMID:
18600182
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

In vivo vaccination with tumor cell lysate plus CpG oligodeoxynucleotides eradicates murine glioblastoma.

Wu A, Oh S, Gharagozlou S, Vedi RN, Ericson K, Low WC, Chen W, Ohlfest JR.

J Immunother. 2007 Nov-Dec;30(8):789-97.

PMID:
18049330
[PubMed - indexed for MEDLINE]
12.

HMGB1 release induced by liver ischemia involves Toll-like receptor 4 dependent reactive oxygen species production and calcium-mediated signaling.

Tsung A, Klune JR, Zhang X, Jeyabalan G, Cao Z, Peng X, Stolz DB, Geller DA, Rosengart MR, Billiar TR.

J Exp Med. 2007 Nov 26;204(12):2913-23. Epub 2007 Nov 5.

PMID:
17984303
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Influence of oxygen tension on CD133 phenotype in human glioma cell cultures.

Platet N, Liu SY, Atifi ME, Oliver L, Vallette FM, Berger F, Wion D.

Cancer Lett. 2007 Dec 18;258(2):286-90. Epub 2007 Oct 30.

PMID:
17977646
[PubMed - indexed for MEDLINE]
14.

Cell based cancer vaccines: regulatory and commercial development.

Copier J, Ward S, Dalgleish A.

Vaccine. 2007 Sep 27;25 Suppl 2:B35-46. Review.

PMID:
17916462
[PubMed - indexed for MEDLINE]
15.

Adaptive landscapes and emergent phenotypes: why do cancers have high glycolysis?

Gillies RJ, Gatenby RA.

J Bioenerg Biomembr. 2007 Jun;39(3):251-7. Review.

PMID:
17624581
[PubMed - indexed for MEDLINE]
16.

Development of TLR9 agonists for cancer therapy.

Krieg AM.

J Clin Invest. 2007 May;117(5):1184-94. Review.

PMID:
17476348
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Transposon-based interferon gamma gene transfer overcomes limitations of episomal plasmid for immunogene therapy of glioblastoma.

Wu A, Oh S, Ericson K, Demorest ZL, Vengco I, Gharagozlou S, Chen W, Low WC, Ohlfest JR.

Cancer Gene Ther. 2007 Jun;14(6):550-60. Epub 2007 Apr 6.

PMID:
17415381
[PubMed - indexed for MEDLINE]
18.

Hypoxia and adaptive landscapes in the evolution of carcinogenesis.

Gillies RJ, Gatenby RA.

Cancer Metastasis Rev. 2007 Jun;26(2):311-7. Review.

PMID:
17404691
[PubMed - indexed for MEDLINE]
19.

Therapeutic potential of Toll-like receptor 9 activation.

Krieg AM.

Nat Rev Drug Discov. 2006 Jun;5(6):471-84. Review.

PMID:
16763660
[PubMed - indexed for MEDLINE]
20.

Dendritic cell vaccination in glioblastoma patients induces systemic and intracranial T-cell responses modulated by the local central nervous system tumor microenvironment.

Liau LM, Prins RM, Kiertscher SM, Odesa SK, Kremen TJ, Giovannone AJ, Lin JW, Chute DJ, Mischel PS, Cloughesy TF, Roth MD.

Clin Cancer Res. 2005 Aug 1;11(15):5515-25.

PMID:
16061868
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk